AstraZeneca joins with Care Access Research on COVID-19 antibody trial
2/23/2021 - Outsourcing Pharma
How we are making a difference in the fight against COVID-19
“Typically with trials, we have to bring the patients to us. This is the first of its kind, where Care Access Research is actually bringing the trial to them.”
Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
01/26/2021 - Care Access
Lilly, Care Access Take COVID Trial Directly To Patients
12/10/2020 - Clinical Leader
Lilly, NIAID & Care Access Research Transform How Studies Done to Reach Nursing Homes During COVID-19 Pandemic
10/12/2020 - Trial Site News
How Lilly’s COVID-19 Nursing Home Trial Could Change the Future of Research in Long-Term Care
10/11/2020 - Skilled Nursing News
A top US drugmaker is teaming up with the Gates Foundation to get a promising new coronavirus treatment to low-income countries before April 2021
10/08/2020 - Business Insider
Eli Lilly Asks FDA to Authorize Covid-19 Antibody Drug
10/07/2020 - Wall Street Journal
Care Access Research Partners on Mobile Trial for COVID-19 Treatment
10/01/2020 - Applied Clinical Trials
An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims
09/16/2020 - New York Times
An ‘Unprecedented’ Effort to Stop the Coronavirus in Nursing Homes
08/20/2020 - New York Times
Care Access Research Validation Study of COVID-19 At-Home Saliva Test by Phosphorus is Granted EUA by FDA
7/02/2020 - Care Access Research
Care Access Research Launches COVID-19 Clinical Trials Alliance to Accelerate Vaccine and Drug Development
4/09/2020 - Care Access Research
We are the founding member of the COVID-19 Clinical Trials Alliance, whose goal is to foresee and remove the logistical bottlenecks inherent to the clinical trial industry, so that we can save lives and end the pandemic.
